文献速递神经肿瘤

脑膜瘤诊断与治疗关键免疫细胞及基因的鉴定

Identification of the Key Immune Cells and Genes for the Diagnostics and Therapeutics of Meningioma.
PubMed 文献 · World Neurosurg · 2023-05-30

该研究纳入4个基因表达综合数据库数据集,采用CIBERSORT算法分析脑膜瘤免疫细胞浸润,并利用多种机器学习方法鉴定差异浸润免疫细胞与差异表达基因。结果显示浆细胞、M1/M2巨噬细胞、中性粒细胞、嗜酸性粒细胞和活化NK细胞为显著差异浸润免疫细胞,共鉴定951个差异表达基因,其中ADCY1具有良好诊断效能,ADCY1、BMX、KCNA5、SLCO4A1和TTR可考虑作为治疗靶点。

要点

  • 浆细胞、M1/M2巨噬细胞、中性粒细胞、嗜酸性粒细胞和活化NK细胞在脑膜瘤中显著差异浸润。
  • 共鉴定951个差异表达基因,与突触功能结构、离子转运调节、脑功能及免疫相关通路有关。
  • ADCY1具有良好诊断效能,ADCY1、BMX、KCNA5、SLCO4A1和TTR可考虑作为治疗靶点。

核心结论

  • ADCY1可作为诊断标志物;ADCY1、BMX、KCNA5、SLCO4A1和TTR为潜在治疗靶点,其与巨噬细胞、中性粒细胞、NK细胞和浆细胞的关联可能影响脑膜瘤发生。

研究设计与样本

  • 纳入4个基因表达综合数据库数据集,采用CIBERSORT算法分析免疫细胞浸润。
  • 采用Wilcoxon检验、随机森林算法和最小绝对收缩与选择算子回归鉴定显著差异浸润免疫细胞和差异表达基因。
  • 通过京都基因与基因组百科全书和基因本体论进行功能富集分析,采用Spearman相关分析评估基因与免疫细胞相关性,受试者工作特征曲线分析评估标志物诊断效能。

主要发现

  • 浆细胞、M1巨噬细胞、M2巨噬细胞、中性粒细胞、嗜酸性粒细胞和活化NK细胞为脑膜瘤中显著差异浸润的免疫细胞。
  • 共鉴定951个差异表达基因,与突触功能与结构、离子转运调节、脑功能和免疫相关通路相关。
  • 在11个枢纽差异表达基因中,RYR2和TTR与浆细胞相关;SNCG与NK细胞相关;ADCY1表现出良好诊断效能;ADCY1、BMX、KCNA5、SLCO4A1和TTR可考虑作为治疗靶点。

关键数值与推荐

  • ADCY1可被鉴定为诊断标志物。
  • ADCY1、BMX、KCNA5、SLCO4A1和TTR为潜在治疗靶点。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dysregulation of immune infiltration critically contributes to the tumorigenesis and progression of meningiomas. However, the landscape of immune microenvironment and key genes correlated with immune cell infiltration remains unclear. METHODS: Four Gene Expression Omnibus data sets were included. CIBERSORT algorithm was utilized to analyze the immune cell infiltration in samples. Wilcoxon test, Random Forest algorithm, and Least Absolute Shrinkage and Selection Operator regression were adopted in identifying significantly different infiltrating immune cells and differentially expressed genes (DEGs). Functional enrichment analysis was performed by Kyoto Encyclopedia of Genes and Genomes and Gene Ontology. The correlation between genes and immune cells was evaluated via Spearman's correlation analysis. Receiver Operator Characteristic curve analysis evaluated the markers' diagnostic effectiveness. The mRNA-miRNA and Drug-Gene-Immune cell interaction networks were constructed to identify potential diagnostic and therapeutic targets. RESULTS: Plasma cells, M1 macrophages, M2 macrophages, neutrophils, eosinophils, and activated NK cells were the significantly different infiltrating immune cells in meningioma. A total of 951 DEGs, associated with synaptic function and structure, ion transport regulation, brain function, and immune-related pathways, were identified. Among 11 hub DEGs, RYR2 and TTR were correlated with plasma cells; SNCG was associated with NK cells; ADCY1 exhibited excellent diagnostic effectiveness; and ADCY1, BMX, KCNA5, SLCO4A1, and TTR could be considered as therapeutic targets. CONCLUSIONS: ADCY1 can be identified as a diagnostic marker; ADCY1, BMX, KCNA5, SLCO4A1, and TTR are potential therapeutic targets, and their associations with macrophages, neutrophils, NK cells, and plasma cells might impact the tumorigenesis of meningiomas.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Chen J, Hua L, Xu X, et al. Identification of the Key Immune Cells and Genes for the Diagnostics and Therapeutics of Meningioma. World Neurosurg. 2023. PMID: 37263494. doi:10.1016/j.wneu.2023.05.090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。